A new imaging system unveiled Thursday in the Essex Centre of Research (CORe) will enable high-quality analysis of DNA, RNA, and proteins collected from cells and tissues — benefiting at least eight cutting-edge cancer research programs at the University of Windsor.
The purchase of the FluorChem-HD2 Imaging System was supported by Caesars Windsor, which contributed $10,000 from its Concerts for a Cure campaign and a further $5,000 annual commitment to local cancer programs.
Dora Cavallo Medved, translational research director for the Windsor Cancer Research Group, said those contributions make a difference.
“We are extremely grateful to Caesars Windsor for recognizing the impact of research equipment and its significance to advancing the field,” she said. “Enhancing the infrastructure available for cancer research is critical for moving discovery forward and for training the next generation of scientists and clinicians.”
Susanne Tomkins, the casino’s public relations manager, said the company is honoured to partner with the group, which unites academic cancer researchers from the University of Windsor with clinical researchers at Windsor Regional Hospital, local oncologists, and other health care professionals working in the field of cancer treatment and care.
“We are a long-time proud supporter of the Windsor Cancer Research Group as they continue to strengthen world-renowned cancer research programs here in our community,” Tomkins said.